Zymeworks Inc.
ZYME- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937653
No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Zymeworks Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- +15 vs. Q2 2021
- Shares held
- 36.8M
- +3.38M (+10.1%) vs. Q2 2021
- Total value
- $1.07B
- −$93.7M (−8.1%) vs. Q2 2021
- New holders
- 30
- 40 more added
- Sold out
- 15
- 29 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZYME on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $1.79B |
| Q1 2026 | 212 | $1.76B |
| Q4 2025 | 210 | $1.88B |
| Q3 2025 | 184 | $1.26B |
| Q2 2025 | 182 | $949.0M |
| Q1 2025 | 186 | $840.9M |
| Q4 2024 | 174 | $973.2M |
| Q3 2024 | 163 | $834.7M |
| Q2 2024 | 164 | $580.6M |
| Q1 2024 | 171 | $713.0M |
| Q4 2023 | 157 | $674.0M |
| Q3 2023 | 140 | $395.5M |
| Q2 2023 | 137 | $547.9M |
| Q1 2023 | 116 | $512.6M |
| Q4 2022 | 96 | $449.9M |
| Q3 2022 | 91 | $293.7M |
| Q2 2022 | 114 | $253.3M |
| Q1 2022 | 120 | $327.3M |
| Q4 2021 | 114 | $693.9M |
| Q3 2021 | 123 | $1.07B |
| Q2 2021 | 109 | $1.20B |
| Q1 2021 | 125 | $1.12B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Zymeworks Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Raymond James & Associates | 293,822 | $8.53M | 0.01% | +33,158+12.7% | Added |
| Alyeska Investment Group, L.P. | 295,923 | $8.59M | 0.11% | +72,103+32.2% | Added |
| Thrivent Financial for Lutherans | 369,103 | $10.7M | 0.02% | +46,739+14.5% | Added |
| Sofinnova Investments, Inc. | 410,619 | $11.9M | 0.76% | +410,619 | New |
| Artal Group S.A. | 450,000 | $13.1M | 0.32% | 00.0% | Unchanged |
| Wellington Management Group LLP | 599,135 | $17.4M | 0.00% | +599,135 | New |
| UBS Asset Management Americas Inc | 667,989 | $19.4M | 0.01% | −116,355−14.8% | Reduced |
| Camber Capital Management LP | 750,000 | $21.8M | 0.81% | +750,000 | New |
| BlackRock Inc. | 778,299 | $22.6M | 0.00% | −193,434−19.9% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 848,725 | $24.6M | 0.09% | +61,941+7.9% | Added |
| Redmile Group, LLC | 882,097 | $25.6M | 0.45% | −57,600−6.1% | Reduced |
| Cormorant Asset Management, LP | 950,000 | $27.6M | 1.12% | −371,936−28.1% | Reduced |
| Lone Pine Capital LLCSuperinvestorLone Pine Capital | 976,735 | $28.4M | 0.10% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,257,034 | $36.5M | 0.01% | −500.0% | Reduced |
| Price T Rowe Associates Inc | 1,697,313 | $49.3M | 0.00% | +647,666+61.7% | Added |
| Baker Bros. Advisors LP | 1,708,472 | $49.6M | 0.22% | 00.0% | Unchanged |
| Pictet Asset Management SA | 1,767,508 | $51.3M | 0.06% | +1,767,508 | New |
| Morgan Stanley | 2,296,422 | $66.7M | 0.01% | −20,225−0.9% | Reduced |
| Credit Suisse AG | 2,346,518 | $68.1M | 0.06% | +1580.0% | Added |
| Armistice Capital, LLC | 2,524,000 | $73.3M | 1.81% | +524,000+26.2% | Added |
| FMR LLC | 3,478,929 | $101.0M | 0.01% | +15,997+0.5% | Added |
| Perceptive Advisors LLC | 3,679,845 | $106.9M | 1.56% | −625,755−14.5% | Reduced |
| Eventide Asset Management, LLC | 3,729,189 | $108.3M | 1.43% | +528,461+16.5% | Added |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −923,578−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −473,124−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −78,300−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −70,351−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −36,810−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −28,975−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −25,452−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −17,260−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,080−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| Indie Asset Partners, LLC | 0 | $0 | 0.00% | −6,450−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −6,245−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −5,961−100.0% | Sold out |
| Exane Derivatives | 0 | $0 | 0.00% | −632−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |